This helps us create a treatment plan just for you
is supported as an Emeritus NIHR Senior Investigator and by the NIHR Sheffield Biomedical Research Centre (IS-BRC-1215-20017), the Motor Neurone Disease Association (AMBRoSIA MNDA 974-797) the Medical Research Council (MRC COEN 4017), the EU Horizon 2020 programme (H2020-633413) and the My Name5 Doddie Foundation (DOD/14/43)
Many patients report this as the point where the medication feels like it has kicked in in a meaningful way
Using a DNA-based bioreceptor (called an aptamer), the sensor was designed to detect phenylalanine, and a key biomarker released during muscle breakdown or after eating protein
Despite the provision of regular clinical appointments, many GLP-1 patients seek structured monitoring and personalised guidance in between their appointments
Not always 15-20% like the high-dose clinical trials, but 5-10% is common